Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.9100
+0.0069 (0.76%)
At close: Sep 26, 2025, 4:00 PM EDT
0.9338
+0.0238 (2.62%)
After-hours: Sep 26, 2025, 6:30 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $81.63 million as of September 26, 2025. Its market cap has decreased by -49.14% in one year.
Market Cap
81.63M
Enterprise Value
-1.72M
1-Year Change
-49.14%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $81.63M, an increase of 59.97%. That is a compound annual growth rate of 12.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 81.63M | -13.33% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |